financetom
Business
financetom
/
Business
/
Advanced Drainage Q2 revenue growth beats estimates, helped by acqusitions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Advanced Drainage Q2 revenue growth beats estimates, helped by acqusitions
Nov 6, 2025 4:24 AM

Overview

* Advanced Drainage Systems ( WMS ) Q2 revenue grows 8.7%, beating analyst expectations

* Adjusted EPS for Q2 beats consensus, driven by acquisitions and market growth

* Company announces acquisition of NDS to enhance product offerings and market reach

Outlook

* Company expects fiscal 2026 net sales between $2.900 bln and $2.990 bln

* Adjusted EBITDA for fiscal 2026 expected between $900 mln and $940 mln

* Capital expenditures for fiscal 2026 projected between $200 mln and $225 mln

Result Drivers

* ACQUISITIONS - Inorganic growth from Orenco and River Valley Pipe contributed 3.6% of the Q2 revenue increase

* PRODUCT MIX - Favorable price/cost and product mix resulted in a resilient Adjusted EBITDA margin of 33.8%

* INFILTRATOR GROWTH - Infiltrator sales increased 25.2% due to Orenco acquisition and growth in tanks and advanced treatment products

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $850.38 $801.39

mln mln (9

Analysts

)

Q2 Beat $1.97 $1.67 (6

Adjusted Analysts

EPS )

Q2 EPS $1.99

Q2 Net $156.50

Income mln

Q2 Beat $287.50 $249.50

Adjusted mln mln (8

EBITDA Analysts

)

Q2 $223.30

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the construction supplies & fixtures peer group is "buy"

* Wall Street's median 12-month price target for Advanced Drainage Systems Inc ( WMS ) is $159.00, about 15.3% above its November 5 closing price of $134.73

* The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sarepta Therapeutics Q4 Non-GAAP Earnings, Revenue Rise
Sarepta Therapeutics Q4 Non-GAAP Earnings, Revenue Rise
Feb 26, 2025
04:48 PM EST, 02/26/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported Q4 non-GAAP net earnings late Wednesday of $1.90 per diluted share, up from $0.82 a year earlier. Analysts polled by FactSet expected $2.00. Total revenue for the quarter ended Dec. 31 was $658.4 million, up from $396.8 million a year earlier. Analysts surveyed by FactSet expected $636.1...
O Reilly Automotive Insider Sold Shares Worth $2,667,481, According to a Recent SEC Filing
O Reilly Automotive Insider Sold Shares Worth $2,667,481, According to a Recent SEC Filing
Feb 26, 2025
04:47 PM EST, 02/26/2025 (MT Newswires) -- Jason Lee Tarrant, Executive Vice President, Store Operations & Sales, on February 25, 2025, sold 1,992 shares in O Reilly Automotive (ORLY) for $2,667,481. Following the Form 4 filing with the SEC, Tarrant has control over a total of 1,459 common shares of the company, with 1,398 shares held directly and 61 controlled...
Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set
Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set
Feb 26, 2025
04:49 PM EST, 02/26/2025 (MT Newswires) -- Chemed ( CHE ) reported Q4 adjusted earnings late Wednesday of $6.83 per diluted share, up from $6.60 a year earlier. Three analysts surveyed by FactSet expected $6.78. Revenue for the quarter ended Dec. 31 was $640 million, up from $585.9 million a year earlier. Three analysts polled by FactSet expected $636.1 million....
Universal Health Services Q4 Adjusted Earnings, Revenue Increase -- Shares Rise After Hours
Universal Health Services Q4 Adjusted Earnings, Revenue Increase -- Shares Rise After Hours
Feb 26, 2025
04:48 PM EST, 02/26/2025 (MT Newswires) -- Universal Health Services ( UHS ) reported Q4 adjusted earnings late Wednesday of $4.92 per diluted share, up from $3.13 a year earlier. Analysts polled by FactSet expected $4.14. Net revenue for the quarter ended Dec. 31 was $4.11 billion, up from $3.70 billion a year earlier. Analysts surveyed by FactSet expected $4.01...
Copyright 2023-2026 - www.financetom.com All Rights Reserved